Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug conjugates—an emerging approach to treat breast cancer
Mahmud Hasan, Rehana K. Leak, Robert E. Stratford, et al.
Pharmacology Research & Perspectives (2018) Vol. 6, Iss. 4
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Design and synthesis of pentacyclic triterpene conjugates and their use in medicinal research
Jiří Hodoň, Lucie Borková, J. Pokorný, et al.
European Journal of Medicinal Chemistry (2019) Vol. 182, pp. 111653-111653
Closed Access | Times Cited: 89
Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy
Osama M. Soltan, Mai E. Shoman, Salah A. Abdel‐Aziz, et al.
European Journal of Medicinal Chemistry (2021) Vol. 225, pp. 113768-113768
Closed Access | Times Cited: 87
Therapeutic potential of polypeptide-based conjugates: Rational design and analytical tools that can boost clinical translation
Tetiana Melnyk, Snežana Đorđević, Inmaculada Conejos‐Sánchez, et al.
Advanced Drug Delivery Reviews (2020) Vol. 160, pp. 136-169
Open Access | Times Cited: 61
Modeling of chitosan modified PLGA atorvastatin-curcumin conjugate (AT-CU) nanoparticles, overcoming the barriers associated with PLGA: An approach for better management of atherosclerosis
Rasmita Dash, Madhulika Yadav, Jyotirmaya Biswal, et al.
International Journal of Pharmaceutics (2023) Vol. 640, pp. 123009-123009
Closed Access | Times Cited: 18
Polymeric and small molecule-conjugates of temozolomide as improved therapeutic agents for glioblastoma multiforme
Reena Jatyan, Prabhjeet Singh, Deepak Kumar Sahel, et al.
Journal of Controlled Release (2022) Vol. 350, pp. 494-513
Closed Access | Times Cited: 26
Gefitinib-Tamoxifen Hybrid Ligands as Potent Agents against Triple-Negative Breast Cancer
Carine M. Abdelmalek, Zexi Hu, Thales Kronenberger, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 6, pp. 4616-4632
Closed Access | Times Cited: 25
Temozolomide–Doxorubicin Conjugate as a Double Intercalating Agent and Delivery by Apoferritin for Glioblastoma Chemotherapy
Ke Du, Qiuyu Xia, Hao Heng, et al.
ACS Applied Materials & Interfaces (2020) Vol. 12, Iss. 31, pp. 34599-34609
Closed Access | Times Cited: 39
Pharmacological, Mechanistic, and Pharmacokinetic Assessment of Novel Melatonin-Tamoxifen Drug Conjugates as Breast Cancer Drugs
Mahmud Hasan, Mohamed Akmal Marzouk, Saugat Adhikari, et al.
Molecular Pharmacology (2019) Vol. 96, Iss. 2, pp. 272-296
Open Access | Times Cited: 38
Current Advances in PARP1‐Targeted Theranostics
Jie Tong, Baosheng Chen, Tommaso Volpi, et al.
Journal of Labelled Compounds and Radiopharmaceuticals (2025) Vol. 68, Iss. 1-2
Closed Access
Diarylurea derivatives comprising 2,4-diarylpyrimidines: Discovery of novel potential anticancer agents via combined failed-ligands repurposing and molecular hybridization approaches
Ahmed Karam Farag, Ahmed H.E. Hassan, Kyung‐Sook Chung, et al.
Bioorganic Chemistry (2020) Vol. 103, pp. 104121-104121
Closed Access | Times Cited: 26
Recent Advances in Paclitaxel-based Self-Delivery Nanomedicine for Cancer Therapy
Mengjiao Zhou, Shupeng Han, Ömer Aras, et al.
Current Medicinal Chemistry (2020) Vol. 28, Iss. 31, pp. 6358-6374
Open Access | Times Cited: 24
Combination of Conventional Drugs with Biocompounds Derived from Cinnamic Acid: A Promising Option for Breast Cancer Therapy
Lyvia Eloiza de Freitas Meirelles, Maria Vítoria Felipe de Souza, Lucimara Rodrigues Carobeli, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 275-275
Open Access | Times Cited: 9
Drug–drug conjugates of MEK and Akt inhibitors for RAS-mutant cancers
Hikaru Fujita, Sachiko Arai, Hiroshi Arakawa, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 102, pp. 117674-117674
Closed Access | Times Cited: 3
A New Paradigm in the Relationship between Melatonin and Breast Cancer: Gut Microbiota Identified as a Potential Regulatory Agent
Aurora Laborda-Illanes, Lidia Sánchez‐Alcoholado, Soukaina Boutriq, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3141-3141
Open Access | Times Cited: 19
Designing a novel drug–drug conjugate as a prodrug for breast cancer therapy: in silico insights
Sankar Muthumanickam, Balajee Ramachandran, Jeyaraman Jeyakanthan, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 2
Development of a Supermolecular Radionuclide-Drug Conjugate System for Integrated Radiotheranostics for Non-small Cell Lung Cancer
Xinmiao Lu, Yunyun Zhu, Xiaohui Deng, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 13, pp. 11152-11167
Closed Access | Times Cited: 2
Exciting Potential of Nanoparticlized Lipidic System for Effective Treatment of Breast Cancer and Clinical Updates: A Translational Prospective
Ranjit K. Harwansh, Shiv Bahadur, Rohitas Deshmukh, et al.
Current Pharmaceutical Design (2020) Vol. 26, Iss. 11, pp. 1191-1205
Closed Access | Times Cited: 17
Chebulinic acid inhibits MDA‐MB‐231 breast cancer metastasis and promotes cell death through down regulation of SOD1 and induction of autophagy
Akshay Sharma, Tripti Mishra, Gatha Thacker, et al.
Cell Biology International (2020) Vol. 44, Iss. 12, pp. 2553-2569
Closed Access | Times Cited: 16
Dual PARP and RAD51 Inhibitory Drug Conjugates Show Synergistic and Selective Effects on Breast Cancer Cells
Matthews M. Malka, Julia Eberle, Kathrin Niedermayer, et al.
Biomolecules (2021) Vol. 11, Iss. 7, pp. 981-981
Open Access | Times Cited: 13
1-Fluoro-1-sulfonyloxylation of Alkenes by Sterically and Electronically Tuned Hypervalent Iodine: Regression Analysis toward 1,1-Heterodifunctionalization
Masaki Fujie, Kyohei Mizufune, Yoshihiro Nishimoto, et al.
Organic Letters (2023) Vol. 25, Iss. 5, pp. 766-770
Closed Access | Times Cited: 5
Synthesis and Photodynamic Activity of Vitamin–Chlorin Conjugates at Nanomolar Concentrations against Prostate Cancer Cells
Meden F. Isaac-Lam, Dewana M. Hammonds
ACS Omega (2019) Vol. 4, Iss. 26, pp. 21712-21723
Open Access | Times Cited: 13
Synthesis and anti‐inflammatory effects of novel emodin derivatives bearing azole moieties
Xiaokang Zhu, Qifang Chen, Yu-Jin Yang, et al.
Archiv der Pharmazie (2019) Vol. 353, Iss. 2
Closed Access | Times Cited: 13
Pyrrolizine/Indolizine-NSAID Hybrids: Design, Synthesis, Biological Evaluation, and Molecular Docking Studies
Mohammed A. S. Abourehab, Alaa M. Alqahtani, Faisal A. Almalki, et al.
Molecules (2021) Vol. 26, Iss. 21, pp. 6582-6582
Open Access | Times Cited: 11
Drug repurposing a compelling cancer strategy with bottomless opportunities
Sujata Mohapatra, Madhulika Yadav, Jyotirmaya Biswal, et al.
Indian Journal of Pharmacology (2023) Vol. 55, Iss. 5, pp. 322-331
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top